Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11599345 | 1.00 | CA2 (0.70) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL10741536 | 1.00 | CA2 (0.70) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL10592049 | 0.98 | CA2 (0.68) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL28929068 | 0.95 | CA2 (0.72) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL11305869 | 0.95 | CA2 (0.72) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL28000856 | 0.95 | CA2 (0.72) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| Zinc Ion SCHEMBL6051381 | 0.95 | CA2 (0.72) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL11119762 | 0.95 | CA2 (0.72) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL11309621 | 0.95 | CA2 (0.72) | CA2NFKB1CYP3A4TSHRNPSR1 | |
| SCHEMBL11118882 | 0.95 | CA2 (0.72) | CA2NFKB1CYP3A4TSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4729526-A2 | BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS | Galata Chemicals, LLC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260092210-A1 | BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS | GALATA CHEMICALS LLC (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092210-A1 | BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS | MGMT, TST, MPST | CA2 2833/4885NFKB1 4184/4885CYP3A4 1692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.